Biopsy instrument offers a full-core option for breast node biopsy

The BioPince Ultra biopsy instrument offers more tissue volume with a reduced risk of crush artefact and tissue fragmentation. According to Argon Medical (formerly Mana-Tech) the original BioPince is the choice of full-core biopsy instrument in many radiology departments across the UK. “So why isn’t it being used widely by breast radiologists? There was no front-firing option for regular ultrasound-guided breast biopsies,” states the company.

BioPince Ultra
Top: BioPince Ultra full-core biopsy instrument.
Bottom: Conventional side notch biopsy instrument.

The next generation of BioPince, BioPince Ultra, is now available with improved handling and provides both front-fire and rear-fire options. It also provides the same quality specimen as the original BioPince.

Initially, the focus will be on node biopsies where BioPince Ultra can deliver a high volume sample on the shortest (13mm) throw. BioPince is regularly used to biopsy peripheral lesions with a 13mm throw. According to Argon, a recent head and neck presentation on lymphoma cases highlighted the device’s ability to provide diagnostic quality samples in nearly all cases even when targeting very small lesions.

Lead picture: 16G BioPince full-core sample offers up to 58 per cent more glomeruli than a 14G conventional side-notch biopsy instrument. Three adjustable sample lengths (33, 23, 13mm) deliver a good sample even on the shortest throw.

Published on page 17 of the May 2020 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more